The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 9 of the 34 sources its claims cite were checked for support.
The impact of headache in Europe: principal results of the Eurolight project
Open accessAbstract
BACKGROUND: European data, at least from Western Europe, are relatively good on migraine prevalence but less sound for tension-type headache (TTH) and medication-overuse headache (MOH). Evidence on impact of headache disorders is very limited. Eurolight was a data-gathering exercise primarily to inform health policy in the European Union (EU). This manuscript reports personal impact. METHODS: The study was cross-sectional with modified cluster sampling. Surveys were conducted by structured questionnaire, including diagnostic questions based on ICHD-II and various measures of impact, and are reported from Austria, France, Germany, Italy, Lithuania, Luxembourg, Netherlands, Spain and United Kingdom. Different methods of sampling were used in each. The full methodology is described elsewhere. RESULTS: Questionnaires were analysed from 8,271 participants (58% female, mean age 43.4 y). Participation-rates, where calculable, varied from 10.6% to 58.8%. Moderate interest-bias was detected. Unadjusted lifetime prevalence of any headache was 91.3%. Gender-adjusted 1-year prevalences were: any headache 78.6%; migraine 35.3%; TTH 38.2%, headache on ≥15 d/mo 7.2%; probable MOH 3.1%. Personal impact was high, and included ictal symptom burden, interictal burden, cumulative burden and impact on others (partners and children). There was a general gradient of probable MOH > migraine > TTH, and most measures indicated higher impact among females. Lost useful time was substantial: 17.7% of males and 28.0% of females with migraine lost >10% of days; 44.7% of males and 53.7% of females with probable MOH lost >20%. CONCLUSIONS: The common headache disorders have very high personal impact in the EU, with important implications for health policy.
Overview
CoChat Summary
## TL;DR
Eurolight is a cross-sectional, multi-country survey showing that common headache disorders in Europe have very high personal impact, with a clear burden gradient of probable medication-overuse headache (MOH) > migraine > tension-type headache (TTH). The authors caution that the study was not designed as a primary source of prevalence estimates and that interest-bias likely inflated some estimates.
## Key findings
- Among 8,271 analyzed questionnaires from nine countries, gender-adjusted 1-year prevalences were 78.6% for any headache, 35.3% for migraine, 38.2% for TTH, 7.2% for headache on ≥15 days/month, and 3.1% for probable MOH.
- Personal impact showed a consistent gradient of probable MOH > migraine > TTH, and most measures showed higher impact in females.
- Lost useful time was substantial: 17.7% of males and 28.0% of females with migraine lost >10% of days; 44.7% of males and 53.7% of females with probable MOH lost >20%.
- In the main study, 41.7% of participants with headache had it weekly or more often; in the non-responder study, this figure was 24.7%, supporting the authors’ concern about interest-bias.
## Methods
- Design: Cross-sectional survey using modified cluster sampling; structured questionnaire with diagnostic questions based on ICHD-II and multiple impact measures.
- Sample/data: Surveys were conducted in 10 countries (Austria, France, Germany, Ireland, Italy, Lithuania, Luxembourg, Netherlands, Spain, UK), but analyses included nine countries only; 8,271 correctly completed questionnaires were analyzed.
- Analysis: Mostly descriptive analyses; data were pooled without weighting by country population size. Diagnoses were assigned by a computerized algorithm, and non-responder studies were used in four countries to assess participation bias.
## Limitations
- The authors explicitly state that the study was not designed or powered to generate prevalence estimates for individual countries, and that Eurolight should not be seen as a primary source of prevalence estimates.
- The paper states there was moderate interest-bias and that diagnostic uncertainty remained because diagnostic validation was not directly assessed in each translation.
- Evident from the text: participation rates were often low (10.6% to 58.8% where calculable), and the samples were not nationally representative; some additional surveys from patient-organization members were excluded because they were “inevitably biased.”
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
5 Valid · 0 Not valid · 19 Not checked · 76 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It failed to acknowledge the interictal impairments associated with migraine.”
§ The impact of headache in Europe: principal results of the Eurolight project > Background
What the sources say
- Supportedcites [13] Steiner TJ, Stovner LJ, Birbeck GL: Migraine: the seventh disabler. J Headache Pain 2013, 14: 1. 10.1186/1129-2377-14-1 source
In “Migraine: the seventh disabler” (page not supplied), the authors say GBD2010 did not include interictal disability because it was considered inconsistent with measurements of other episodic conditions. They also state that migraine’s disability ranking was based on ictal disability alone. (LLM, conf=0.93)
- Supportedcites [14] Steiner TJ, Stovner LJ, Birbeck GL: Migraine: the seventh disabler. Headache 2013, 53: 227–229. 10.1111/head.12034 source
In “Migraine: The Seventh Disabler” (page not supplied), the authors say GBD2010 excluded interictal disability from its burden estimate because its inclusion was considered inconsistent with measurements for other episodic conditions. They also state that migraine’s ranking was based on ictal disability alone. (LLM, conf=0.92)
- Not checked yetcites [15] Steiner TJ, Stovner LJ, Birbeck GL: Migraine: the seventh disabler. Cephalalgia 2013, 33: 289–290. 10.1177/0333102412473843 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“They are not, however, outside the range of national studies (in Russia, 10.4% and 7.1% respectively were reported [10,26]).”
§ The impact of headache in Europe: principal results of the Eurolight project > Discussion
What the sources say
- Not checked yetcites [10] Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Yakhno N, Steiner TJ: The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 2012, 32: 373–381. 10.1177/0333102412438977 source
- Could not verifycites [26] Stovner LJ, Al Jumah M, Birbeck GL, Gururaj G, Jensen R, Katsarava Z, Queiroz LP, Scher AI, Tekle-Haimanot R, Wang SJ, Steiner TJ: The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache. J Headache Pain 2014, 15: 5. 10.1186/1129-2377-15-5 sourceExperimental — accuracy not yet measured
Our copy of Stovner et al. (2014) is a methodology guidance paper: it discusses sample size, precision/margin of error, participation rate, case definition and how prevalence should be reported (Methodological issues and Reporting the study sections), but nowhere states prevalence figures for Russia or any 10.4% / 7.1% pair. Searches for 'Russia prevalence migraine tension-type headache', '10.4% 7.1%', 'Ayzenberg Russia population-based survey', and 'national studies prevalence comparisons between countries' returned only the reference list entry 14 (Ayzenberg I, Katsarava Z, Mathalikov R, Chernysh M, Osipova V. The burden of headache in Russia: validation of the diagnostic questionnaire in a population-based sample. Eur J Neurol 2011;15:454-459), cited as an example of questionnaire validation, not as a source of reported prevalences. Since the paper does not address the claim's point, the attributed numbers can be neither confirmed nor contradicted here. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lifetime prevalence by gender (overall) was 87.5% in males and 94.3% in females; in males, life-time prevalence peaked at 92.8% in the age range 20–30 y, whereas in females there was a plateau at 96-97% in the age range 20–50 y.”
§ The impact of headache in Europe: principal results of the Eurolight project > Results
plainn = 8,271- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The 1-year prevalence was 79.6% overall, 71.1% in males (with a peak of 81.3% in the age-range 30–40 y) and 86.0% in females (peaking at 92.7% in the age-range 20–30 y).”
§ The impact of headache in Europe: principal results of the Eurolight project > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From these nine countries, 8,271 correctly completed questionnaires were analysed.”
§ The impact of headache in Europe: principal results of the Eurolight project > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
49 more claims
Create a free account to see all 100 claims and to verify the 25 references still open.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 33
Citations
Cites
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationThe International Classification of Headache Disorders: 2nd edition
Olesen, J., Goadsby, P., & Steiner, T. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00590-8 · Cited by 5,049
Self-citationThe global burden of headache: A documentation of headache prevalence and disability worldwide
Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444 · cited 3×
“3%) is outside the range of other published studies [2], even recent LTB studies which, with very careful case-ascertainment, have generally found migraine to be more prevalent than previously reported (eg, 20.”
BackgroundResultSelf-citationGoadsby, P. J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00711.x · Cited by 2,381
The International Classification of Headache Disorders
Olesen, J. (2008) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01121.x · Cited by 2,321
Olesen, J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2003.00824.x · Cited by 2,056
The cost of headache disorders in Europe: the Eurolight project
Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri‐Minet, M., Rastenyte, D., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03612.x · Cited by 741 · cited 3×
“The inescapable financial implications of such losses, reported in detail elsewhere [19], again show a clear gradient at personal level of probable MOH> migraine > TTH.”
BackgroundInfluentialSelf-citationStewart, W. F., Lipton, R. B., Kolodner, K. B., Sawyer, J., Lee, C., & Liberman, J. N. (2000) · Pain · doi:10.1016/s0304-3959(00)00305-5 · Cited by 622
Prevalence of headache in Europe: a review for the Eurolight project
Stovner, L. J., & Andree, C. (2010) · The Journal of Headache and Pain · doi:10.1007/s10194-010-0217-0 · Cited by 580 · cited 1×
“As far as Europe is concerned, good data exist on migraine prevalence derived from a number of western countries [17,18].”
BackgroundSelf-citationBebbington, P. (2001) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270170010 · Cited by 513
Research works printed but not linked: 4
- World Health Organization and Lifting The Burden: ATLAS of headache disorders and resources in the world 2011. World Health Organization, Geneva; 2011.
- Peters M, Bertelote JM, Houchin C, Kandoura T, Steiner TJ: Translation protocols. J Headache Pain 2007, 8: S40-S47.
- Index Mundi: European Union Demographics Profile 2013. 2013. http://www.indexmundi.com/european_union/sex_ratio.html
- Steiner TJ: The HALT and HART indices. J Headache Pain 2007, 8: S22-S25.
Cited by
Migraine: epidemiology and systems of care
Ashina, M., Katsarava, Z., Do, T. P., Buse, D. C., Pozo-Rosich, P., Özge, A., Krymchantowski, A. V., Lebedeva, E. R., Ravishankar, K., Yu, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32160-7 · Cited by 833
Self-citationMigraine is first cause of disability in under 50s: will health politicians now take notice?
Steiner, T. J., Stovner, L. J., Vos, T., Jensen, R., & Katsarava, Z. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0846-2 · Cited by 642
“A considerable strength of this study, apart from its size and geographical scope, was the use in all countries of the same questionnaire [12], a derivative of the HARDSHIP questionnaire already employed in many different countries, cultures and translations [13].”
MethodSelf-citationGlobal epidemiology of migraine and its implications for public health and health policy
Steiner, T. J., & Stovner, L. J. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00763-1 · Cited by 388
Self-citationSteiner, T., & Saylor, D. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1646946 · Cited by 324
Self-citationBuse, D. C., Fanning, K. M., Reed, M. L., Murray, S., Dumas, P. K., Adams, A. M., & Lipton, R. B. (2019) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13613 · Cited by 311
“Our results related to career and finance were consistent with those reported by others.(14,18-22).”
BackgroundResult
Metadata
- Authors
- Steiner, T. J., Stovner, L. J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., Barré, J., & Andrée, C.
- Affiliations
- Norwegian University of Science and Technology (NO)
- Essen University Hospital (DE)
- University of Pavia (IT)
- Centre de Recherche Public de la Santé (LU)
- University of Basel (CH)
- Corresponding author
- Steiner, Timothy J
- ORCID
- Venue
- The Journal of Headache and Pain
- Published
- 2014-05-21
- Volume
- 15
- Issue
- 1
- Pages
- 31-31
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- PMC
- PMC4045992
- OpenAlex
- W2163981252
- Cited by
- 382
- References
- 30
- Citations by year
- 2026: 17 · 2025: 30 · 2024: 37 · 2023: 41 · 2022: 40 · 2021: 44 · 2020: 42 · 2019: 38 · 2018: 29 · 2017: 19 · 2016: 22 · 2015: 20 · 2014: 1
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The Journal of Headache and Pain (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lithuanian University of Health Sciences (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Funders
- European Commission
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Keywords
- headache, migraine, tension-type headache, medication overuse headache, symptom burden, prevalence, sex differences, health policy
- MeSH terms
- Adult, Age Factors, Aged, Cross-Sectional Studies, Europe, Female, Headache, Health Surveys, Humans, Male, Middle Aged, Surveys and Questionnaires, Sex Factors, Prevalence, Tension-Type Headache, Headache Disorders, Headache Disorders, Secondary, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The impact of headache in Europe: principal results of the Eurolight project. https://app.cochat.ai/papers/10.1186/1129-2377-15-31
- The paper
- Steiner, T. J., Stovner, L. J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., Barré, J., & Andrée, C. (2014). The impact of headache in Europe: principal results of the Eurolight project. The Journal of Headache and Pain. https://doi.org/10.1186/1129-2377-15-31
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
